Explore the vast range of titles available.

Background Lung cancer screening reduces lung cancer mortality by at least 20%. If implemented equitably, it has the potential to reduce inequities for Māori (the Indigenous people of Aotearoa New Zealand), whose rates of lung cancer are significantly higher than non-Māori. Our aim was to inform the equitable implementation of potential future lung cancer screening in Aotearoa by understanding the acceptability, decision making processes and design preferences for Māori and their whānau. Methods In 2020, Māori potentially eligible for lung cancer screening ( n  = 388) and their whānau/family members ( n  = 103) completed separate cross-sectional surveys about how a future screening programme could be designed and delivered. The focus of the surveys was to determine the level of support for a lung screening programme and to explore decision making and design preferences for Māori and their whānau. The two surveys were analysed separately with pre-defined responses reported as frequencies and percentages. Fisher’s exact tests were used to compare responses between gender, region, age-group and smoking status. Significant differences were further explored using pairwise comparisons with Bonferroni correction. Free text comments were analysed thematically. Results There was a very high level of support for a lung screening programme. When deciding whether to take part in screening, the strongest preferences were to follow doctors’ advice, followed by deciding alone, or with their whānau. An almost equal proportion of participants preferred to receive an invitation from their GP, or from a screening programme. Preferences for receiving information about the programme varied, with the most common being talking directly to a doctor, followed by reading a brochure, or receiving information via email. The results showed clear differences in preferences between demographic groups, particularly between regions and age-groups. Conclusions Surveys of potentially eligible Māori participants and their whānau have revealed support for screening, but diverse preferences regarding decision making and programme design. These findings have informed a randomised controlled trial on lung cancer screening invitation approaches and will guide the development of a national lung screening programme.

aim: As part of a broader lung cancer screening (LCS) research programme, this study explored Māori views on providing blood samples for LCS to inform future development in Aotearoa New Zealand. methods: Two groups (potential “screenees”, and their whānau tautoko [support people]) from Te Tai Tokerau (Northland) and Tāmaki Makaurau (Auckland) completed surveys about LCS design, including comfort with blood donation and key factors in blood collection and use. Descriptive statistics and Fisher’s tests were used to analyse responses and demographic differences. results: Most participants (83.7% screenees; 81.4% whānau) were at least “comfortable” donating blood. Key priorities were clear information about blood use (35.0%; 35.8%), protecting the health of future generations (24.1%; 23.8%) and being able to consent to specific uses (23.6%; 27.6%). Participants from Te Tai Tokerau were less comfortable donating blood than those in Tāmaki Makaurau, with additional demographic differences noted. conclusions: Māori participants generally supported using blood samples in LCS but with regional differences. Future LCS initiatives should uphold Māori principles, including community partnership, return of benefit to whānau, management of potential harms and protection of Indigenous data and tissue sovereignty through transparent, culturally safe and trusted engagement processes.

aims: Lung cancer causes more deaths than any other cancer, globally and in Aotearoa New Zealand, where it disproportionately affects Māori. We aimed to understand Māori perspectives on lung cancer screening in Aotearoa New Zealand to guide its equity focussed implementation, including identifying enablers and barriers. methods: We took a Kaupapa Māori based co-design approach to inform future screening, recruiting Māori current/ex-smokers and members of their whānau (family) for three focus group phases held in Auckland, Aotearoa New Zealand in August 2019. Participants responded to a proposed lung cancer screening pathway and shared their attitudes and beliefs about lung cancer and screening. Results were thematically analysed. results: The 21 Māori participants supported future lung cancer screening in Aotearoa New Zealand. Perceived benefits included being more informed about lung cancer and screening and enabling healthier future generations. Barriers to screening were previous negative health service experiences; fear; stigma; and access, including time, cost and transport. Enablers included providers’ cultural competence; clear communication; a one-stop shop; and support with transport. A range of factors could potentially influence a decision to participate in screening. conclusions: Participants favoured future lung cancer screening and identified key barriers and facilitators of screening.

Examines wāhine Māori experiences of colposcopy services in Waitematā and Auckland districts based on surveys conducted in 2016 and 2021. Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons Attribution 3.0 New Zealand Licence.